Consequently, the authors propose that ILK could affect the chemosensitivity of ESCC cells to CDDP and that this effect may be mediated by affecting the expression of β-catenin, the key protein in the activation of the Wnt/β-catenin signaling pathway. The gene discussed is ILK; the disease is esophageal squamous cell carcinoma.